![CD40 Ligand/CD154/TRAP1 (Activation Marker of T-Lymphocytes) Monoclonal Antibody (CD40LG, 2763) (959-MSM3-P1) CD40 Ligand/CD154/TRAP1 (Activation Marker of T-Lymphocytes) Monoclonal Antibody (CD40LG, 2763) (959-MSM3-P1)](https://www.thermofisher.com/antibody/images/650/959-MSM3-P1-CD154-CD40-Ligand-SDS-PAGE-1-20210513143032.jpg?time=20220826?time=20220826)
CD40 Ligand/CD154/TRAP1 (Activation Marker of T-Lymphocytes) Monoclonal Antibody (CD40LG, 2763) (959-MSM3-P1)
![The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets | eLife The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets | eLife](https://iiif.elifesciences.org/lax/44245%2Felife-44245-fig8-v2.tif/full/1500,/0/default.jpg)
The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets | eLife
![CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation | Scientific Reports CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-57293-y/MediaObjects/41598_2019_57293_Fig1_HTML.png)
CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation | Scientific Reports
![CD40 Ligand/CD154/TRAP1 (Activation Marker of T-Lymphocytes) Monoclonal Antibody (CD40LG, 2761) (959-MSM1-P1) CD40 Ligand/CD154/TRAP1 (Activation Marker of T-Lymphocytes) Monoclonal Antibody (CD40LG, 2761) (959-MSM1-P1)](https://www.thermofisher.com/antibody/images/650/959-MSM1-P1-CD154-CD40-Ligand-SDS-PAGE-1-20210513143032.jpg?time=20220826?time=20220826)
CD40 Ligand/CD154/TRAP1 (Activation Marker of T-Lymphocytes) Monoclonal Antibody (CD40LG, 2761) (959-MSM1-P1)
![Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma | Nature Communications Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-24347-7/MediaObjects/41467_2021_24347_Fig1_HTML.png)
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma | Nature Communications
![Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis](https://www.mdpi.com/cells/cells-08-00927/article_deploy/html/images/cells-08-00927-g001.png)
Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
![JCM | Free Full-Text | CD40/CD40L Signaling as a Promising Therapeutic Target for the Treatment of Renal Disease JCM | Free Full-Text | CD40/CD40L Signaling as a Promising Therapeutic Target for the Treatment of Renal Disease](https://pub.mdpi-res.com/jcm/jcm-09-03653/article_deploy/html/images/jcm-09-03653-g002.png?1605275291)
JCM | Free Full-Text | CD40/CD40L Signaling as a Promising Therapeutic Target for the Treatment of Renal Disease
![Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients | Arthritis Research & Therapy | Full Text Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-020-02372-z/MediaObjects/13075_2020_2372_Fig4_HTML.png)
Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients | Arthritis Research & Therapy | Full Text
![Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients | Arthritis Research & Therapy | Full Text Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-020-02372-z/MediaObjects/13075_2020_2372_Fig2_HTML.png)
Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients | Arthritis Research & Therapy | Full Text
![Frontiers | Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy Frontiers | Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy](https://www.frontiersin.org/files/Articles/750478/fimmu-12-750478-HTML/image_m/fimmu-12-750478-g001.jpg)
Frontiers | Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy
![Human CD40 ligand–expressing type 3 innate lymphoid cells induce IL-10–producing immature transitional regulatory B cells - ScienceDirect Human CD40 ligand–expressing type 3 innate lymphoid cells induce IL-10–producing immature transitional regulatory B cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0091674917314604-fx1.jpg)
Human CD40 ligand–expressing type 3 innate lymphoid cells induce IL-10–producing immature transitional regulatory B cells - ScienceDirect
![Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis | Journal of the American College of Cardiology Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/97e87174-ac5e-4300-9a76-30970bba1fb1/fx1.jpg)